(Q27746054)

0 references

P Tunnah

0 references

N R Brown

0 references

L N Johnson

0 references

J A Endicott

Nature structural biology

0 references

publication date

October 1997

0 references

published in

0 references

volume

0 references

issue

0 references

page(s)

796-801

0 references

cites work

Structural basis for selectivity of the isoquinoline sulfonamide family of protein kinase inhibitors

1 reference

Absolute Configuration of Staurosporine By X-Ray Analysis

21 April 2017

1 reference

Improved methods for building protein models in electron density maps and the location of errors in these models

21 April 2017

1 reference

Analytical molecular surface calculation

21 April 2017

1 reference

Principles of CDK regulation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Crystal structure of cyclin-dependent kinase 2

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Chemical inhibitors of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Purification and crystallization of human cyclin-dependent kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

[25] Protein multiple sequence alignment and flexible pattern matching

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Staurosporine, a Potentially Important Gift from a Microorganism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Crystal Structure of the Catalytic Subunit of Cyclic Adenosine Monophosphate-Dependent Protein Kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Structural basis of cyclin-dependent kinase activation by phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Domain movements in protein kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

RETRACTED: 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Chemical inhibitors of cyclin-dependent kinases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

11-Hydroxystaurosporine: a highly cytotoxic, powerful protein kinase C inhibitor from a tunicate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

A new inhibitor of protein kinase C, RK-286C (4'-demethylamino-4'-hydroxystaurosporine). I. Screening, taxonomy, fermentation and biological activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

AMoRe: an automated package for molecular replacement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

Multiple protein sequence alignment from tertiary structure comparison: assignment of global and residue confidence levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1097-796

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NSB1097-796

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

9334743

1 reference

Consolidated OpenCitations Corpus – April 2017